Nadine Honke
Duesseldorf, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
ISG15 Drives Immune Pathology and Respiratory Failure during Systemic Lymphocytic Choriomeningitis Virus Infection.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: January 30, 2024
Components of the sympathetic nervous system as targets to modulate inflammation - rheumatoid arthritis synovial fibroblasts as neuron-like cells?
Journal: Journal of inflammation (London, England)
Published: September 20, 2022
Endogenously produced catecholamines improve the regulatory function of TLR9-activated B cells.
Journal: PLoS biology
Published: July 14, 2021
IFN-β, but not IFN-α, is Responsible for the Pro-Bacterial Effect of Type I Interferon.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: March 31, 2021
Combination immunotherapy with anti-PD-L1 antibody and depletion of regulatory T cells during acute viral infections results in improved virus control but lethal immunopathology.
Journal: PLoS pathogens
Published: July 10, 2019
The probacterial effect of type I interferon signaling requires its own negative regulator USP18.
Journal: Science immunology
Published: May 17, 2018
Tumor Necrosis Factor-Mediated Survival of CD169+ Cells Promotes Immune Activation during Vesicular Stomatitis Virus Infection.
Journal: Journal of virology
Published: September 19, 2017
Presentation of Autoantigen in Peripheral Lymph Nodes Is Sufficient for Priming Autoreactive CD8+ T Cells.
Journal: Frontiers in immunology
Published: September 25, 2016
Farnesoid X Receptor in Mice Prevents Severe Liver Immunopathology During Lymphocytic Choriomeningitis Virus Infection.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: August 26, 2016
CD169+ macrophages regulate PD-L1 expression via type I interferon and thereby prevent severe immunopathology after LCMV infection.
Journal: Cell death & disease
Published: July 25, 2016
Last Updated: 09/26/2026